Searchable knowledge base

Chemotherapy-induced peripheral neuropathy is nerve damage caused by certain chemotherapy drugs. It typically appears as tingling, burning, numbness, or weakness — most often beginning in the hands and feet — and can persist after treatment ends.

Yes — nerves have the capacity to regenerate, though slowly (roughly a millimeter per day under good conditions). For many people CIPN improves over months. Consistent, science-informed support helps create the conditions in which recovery is more likely.

Tingling, burning, and numbness reflect disrupted nerve signaling. Damage to myelin (the insulation around nerves), to nerve cell membranes, or to the mitochondria that fuel nerve cells can all distort the signals nerves send to the brain.

Myelin is the fatty insulating sheath that wraps peripheral nerves and lets them transmit signals quickly and clearly. Healthy myelin is essential for normal sensation, movement, and coordination.

Fatty acids are the building blocks of cell membranes — including the lipid bilayer that forms myelin. Specific fatty acids are essential for nerve health and are part of Novilora's patented formulation.

Palmitoylethanolamide (PEA) is a fatty acid amide produced naturally by the body, especially in response to stress or injury. PEA has been studied for its role in supporting healthy inflammatory balance and nerve cell function.

In the STEFANO study, 146 patients with CIPN were evaluated over a three-month period using the patented fatty acid + PEA formulation. Researchers observed improvements and stabilization of sensory and motor neuropathy symptoms in many patients.

Recovery is measured in months, not days. Peripheral nerves regenerate slowly. The published research on Novilora's formulation evaluated a three-month window — a reasonable evaluation period to assess change.

Chemotherapy is the focus of CIPN by definition, but peripheral neuropathy can also arise from many other causes (diabetes, vitamin deficiencies, autoimmune conditions). The science Novilora is built on focuses specifically on the CIPN context.

Cold can amplify sensitivity in nerves that are already compromised. Warming the extremities is a simple, well-tolerated comfort measure for many people with CIPN.

Novilora is a dietary supplement, not a medication. It is intended to support nerve health and is not intended to diagnose, treat, cure, or prevent any disease.

Improvement is usually gradual and quiet — less burning at night, returning sensitivity, easier walking. Tracking small changes over weeks often surfaces meaningful progress.